Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Analysis Covering Size, Share, And Evolving Product Segments

 The Business Research Company’s 2026 market reports incorporate enhanced features, including market attractiveness scoring and analysis, total addressable market evaluation, a company scoring matrix, an interactive Excel data dashboard, refined supply chain analysis, insights on emerging startups, and overviews of key products, all aimed at improving the depth, usability, and strategic relevance of the insights delivered.

 
 What Are The Forecasted Market Size Figures For The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Through 2030?
 The minimally invasive glaucoma surgery (migs) devices market size has grown exponentially in recent years. It will grow from $0.89 billion in 2025 to $1.14 billion in 2026 at a compound annual growth rate (CAGR) of 28.1%. The growth in the historic period can be attributed to increasing prevalence of glaucoma, growing aging population, limitations of conventional glaucoma surgeries, rising awareness of vision preservation, increasing adoption of cataract surgeries.
 
 The minimally invasive glaucoma surgery (migs) devices market size is expected to see exponential growth in the next few years. It will grow to $2.79 billion in 2030 at a compound annual growth rate (CAGR) of 24.9%. The growth in the forecast period can be attributed to expanding glaucoma patient pool, growing acceptance of minimally invasive surgical options, rising demand for outpatient ophthalmic procedures, increasing focus on quality-of-life outcomes, expanding access to specialized ophthalmology clinics. Major trends in the forecast period include rising adoption of minimally invasive glaucoma procedures, growing preference for MIGS in early and moderate glaucoma, increasing use of MIGS in combination with cataract surgery, expansion of outpatient and ambulatory glaucoma surgeries, growing demand for safer and faster-recovery glaucoma treatments.
 
 Download Your Free Report Sample:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=15863&type=smp&utm_source=Blogger&utm_medium=Paid&utm_campaign=Jul_PR
 
 Which Growth Factors Are Influencing The Expansion Of The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market? 
 The increasing prevalence of eye disorders is expected to propel the growth of minimally invasive glaucoma surgery (MIGS) devices going forward. Eye disorders encompass a wide range of conditions that affect the eyes and vision. The prevalence of eye disorders is increasing due to lifestyle changes, environmental influences, and aging populations. Minimally invasive glaucoma surgery (MIGS) devices are innovative tools utilized in managing various eye diseases, primarily focusing on reducing intraocular pressure (IOP) to prevent or control glaucoma progression. For instance, in 2024, according to the National Eye Institute, a US-based government agency, around 2.2 million Americans will be blind or partially blind by 2030. Therefore, the increasing prevalence of eye disorders drives the minimally invasive glaucoma surgery (MIGS) devices market. 
 
 Who Are The Leading Participants In The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?
 The minimally invasive glaucoma surgery (migs) devices market covered in this report is segmented — 
 
 1) By Product Type: Trabecular Micro-Stents, Subconjunctival Micro-Shunts, Suprachoroidal Stents, Canaloplasty & Schlemm’s Canal Devices
 2) By Surgical Approach: MIGS in Conjunction with Cataract Surgery, Stand-Alone MIGS Procedures
 3) By Target Anatomical Pathway: Trabecular Meshwork, Schlemm’s Canal, Suprachoroidal Space, Subconjunctival Space
 4) By Procedure Type: Ab-Interno MIGS, Ab-Externo MIGS
 5) By End User: Ophthalmology Clinics, Ambulatory Surgery Centers (ASCs), Specialized Eye Hospitals
 
 Subsegments:
 1) By Trabecular Micro-Stents: Single-Lumen Trabecular Micro-Stents, Multi-Lumen Trabecular Micro-Stents, Scaffold-Based Trabecular Stents, Drug-Eluting Trabecular Micro-Stents
 2) By Subconjunctival Micro-Shunts: Gel-Based Micro-Shunts, Polymer-Based Micro-Shunts, Collagen-Based Micro-Shunts, Fixed-Lumen Subconjunctival Micro-Shunts
 3) By Suprachoroidal Stents: Passive Suprachoroidal Stents, Flow-Regulated Suprachoroidal Stents, Biocompatible Polymer Suprachoroidal Stents
 4) By Canaloplasty & Schlemm’s Canal Devices: Microcatheter-Based Canaloplasty Devices, Viscodilation & Schlemm’s Canal Expanders, Implant-Free Canaloplasty Systems, Schlemm’s Canal Scaffolding Devices
 
 How Are Current Trends Influencing The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Expansion?
 Major companies operating in the minimally invasive glaucoma surgery (MIGS) devices market are focusing on developing advanced solutions, such as sustained-release drug-delivery implants, to replace traditional topical glaucoma treatments. A sustained-release implant refers to a device that delivers medication continuously over time, improving patient adherence, reducing dosing frequency, and enhancing treatment efficacy. For instance, in February 2024, Celanese Corporation, a US-based specialty materials company, partnered with Glaukos to commercially launch the iDose® TR (Travoprost Intracameral Implant) using Celanese’s VitalDose® Ethylene Vinyl Acetate (EVA) platform. This innovation replaces traditional eye-drop regimens by providing continuous intraocular delivery of travoprost directly to the eye over several months. Integrated with Glaukos’ MIGS portfolio, it offers a minimally invasive therapeutic option that reduces the need for daily eye drops, improves patient compliance, and supports sustained intraocular pressure control, ultimately enhancing long-term treatment outcomes. 
 
 Which Segment Categories Define The Structure Of The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?
 The minimally invasive glaucoma surgery (migs) devices market covered in this report is segmented — 
 
 1) By Product Type: Trabecular Micro-Stents, Subconjunctival Micro-Shunts, Suprachoroidal Stents, Canaloplasty & Schlemm’s Canal Devices
 2) By Surgical Approach: MIGS in Conjunction with Cataract Surgery, Stand-Alone MIGS Procedures
 3) By Target Anatomical Pathway: Trabecular Meshwork, Schlemm’s Canal, Suprachoroidal Space, Subconjunctival Space
 4) By Procedure Type: Ab-Interno MIGS, Ab-Externo MIGS
 5) By End User: Ophthalmology Clinics, Ambulatory Surgery Centers (ASCs), Specialized Eye Hospitals
 
 Subsegments:
 1) By Trabecular Micro-Stents: Single-Lumen Trabecular Micro-Stents, Multi-Lumen Trabecular Micro-Stents, Scaffold-Based Trabecular Stents, Drug-Eluting Trabecular Micro-Stents
 2) By Subconjunctival Micro-Shunts: Gel-Based Micro-Shunts, Polymer-Based Micro-Shunts, Collagen-Based Micro-Shunts, Fixed-Lumen Subconjunctival Micro-Shunts
 3) By Suprachoroidal Stents: Passive Suprachoroidal Stents, Flow-Regulated Suprachoroidal Stents, Biocompatible Polymer Suprachoroidal Stents
 4) By Canaloplasty & Schlemm’s Canal Devices: Microcatheter-Based Canaloplasty Devices, Viscodilation & Schlemm’s Canal Expanders, Implant-Free Canaloplasty Systems, Schlemm’s Canal Scaffolding Devices
 
 Explore the Complete Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Report:
 https://www.thebusinessresearchcompany.com/report/minimally-invasive-glaucoma-surgery-migs-devices-global-market-report?utm_source=Free PR&utm_medium=Paid&utm_campaign=Jul_PR
 
 Which Regions Contribute The Highest Demand In The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?
 North America was the largest region in the minimally invasive glaucoma surgery (MIGS) devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the minimally invasive glaucoma surgery (migs) devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
 
 #Contact Us:#
 
 The Business Research Company: https://thebusinessresearchcompany.com/ 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 Email: info@tbrc.info 
 
 #Follow Us On:#
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company